Home » Bayer Starts Phase III Nexavar Breast Cancer Trial
Bayer Starts Phase III Nexavar Breast Cancer Trial
Bayer and Onyx Pharmaceuticals have started recruiting breast-cancer patients to start the third and last stage of testing their Nexavar pill, a key pipeline drug for both drugmakers.
CNBC
CNBC
Upcoming Events
-
28Mar
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May